Snowdome Foundation and Blood Cancer Research Western Australia (BCRWA) are pleased to announce a new chapter in the delivery of next-generation treatments for Western Australian blood cancer patients.
From 1 January 2023, BCRWA will be forging ahead, operating as its own not-for-profit organisation led by Professor Chan Cheah and an independent Board of Directors.
Back in 2018, the inequity in access to clinical trials for patients in the west compared to the eastern states drove Prof Chan Cheah to seek the support of the Snowdome Foundation. Our aligned purpose was simple; that Western Australians diagnosed with blood cancer were able to access clinical trials in their home state.
Since the very first fundraising event, in which $550,000 was raised to enable BCRWA to employ the team necessary to establish a research centre of excellence, the investment in blood cancer research has delivered life-changing impact. In its first 6 months, the number of blood cancer trials delivered in WA more than doubled from 8 to 19. Today, 4 years later, this number is far greater and more than $2.2M has been raised.
We are incredibly proud to have supported the establishment of BCRWA and played a part in delivering real impact to West Australian blood cancer patients. Looking to the future, we wish Prof Cheah, the Board and the entire team every success and we look forward to collaborating on projects in the region.
Snowdome will continue to support translational research, accelerating access to next-generation treatments for Australian diagnosed with blood cancer to help them live longer, better lives.